Medicare to Update Payment Criteria for Breakthrough Medical Devices

Starting October 2026, Medicare will no longer automatically provide additional payments for FDA-designated breakthrough medical devices. The Centers for Medicare & Medicaid Services (CMS) will now require these devices to demonstrate substantial clinical improvement over existing alternatives to qualify for extra payments. This change aims to ensure that enhanced payments are reserved for innovations offering clear patient benefits, potentially impacting device manufacturers and patient access to new technologies.